Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Recent progress in the research of suicide gene therapy for malignant glioma.

Tamura R, Miyoshi H, Yoshida K, Okano H, Toda M.

Neurosurg Rev. 2019 Nov 28. doi: 10.1007/s10143-019-01203-3. [Epub ahead of print] Review.


Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.

Binello E, Germano IM.

Neuro Oncol. 2012 Mar;14(3):256-65. doi: 10.1093/neuonc/nor204. Epub 2011 Dec 13. Review.


The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells.

Huang Q, Liu XZ, Kang CS, Wang GX, Zhong Y, Pu PY.

Cancer Gene Ther. 2010 Mar;17(3):192-202. doi: 10.1038/cgt.2009.64. Epub 2009 Oct 23.


Genetically Engineered Multilineage-Differentiating Stress-Enduring Cells as Cellular Vehicles against Malignant Gliomas.

Yamasaki T, Wakao S, Kawaji H, Koizumi S, Sameshima T, Dezawa M, Namba H.

Mol Ther Oncolytics. 2017 Jun 15;6:45-56. doi: 10.1016/j.omto.2017.06.001. eCollection 2017 Sep 15.


Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.

Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK, Phi JH, Park IH, Black PM, Carroll RS, Lee J, Kim SK.

Clin Cancer Res. 2009 Aug 1;15(15):4925-34. doi: 10.1158/1078-0432.CCR-08-3076. Epub 2009 Jul 28. Erratum in: Clin Cancer Res. 2010 Nov 1;16(21):5367.


Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.

Ryu CH, Park KY, Kim SM, Jeong CH, Woo JS, Hou Y, Jeun SS.

Biochem Biophys Res Commun. 2012 May 11;421(3):585-90. doi: 10.1016/j.bbrc.2012.04.050. Epub 2012 Apr 14.


Glioma gene therapy using induced pluripotent stem cell derived neural stem cells.

Lee EX, Lam DH, Wu C, Yang J, Tham CK, Ng WH, Wang S.

Mol Pharm. 2011 Oct 3;8(5):1515-24. doi: 10.1021/mp200127u. Epub 2011 Jul 22. Retraction in: Mol Pharm. 2019 Sep 3;16(9):4088.


Lentivirus-mediated CD/TK fusion gene transfection neural stem cell therapy for C6 glioblastoma.

Niu J, Xing C, Yan C, Liu H, Cui Y, Peng H, Chen Y, Li D, Jiang C, Li N, Yang H.

Tumour Biol. 2013 Dec;34(6):3731-41. doi: 10.1007/s13277-013-0957-y. Epub 2013 Jul 5.


Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.

Germano IM, Emdad L, Qadeer ZA, Binello E, Uzzaman M.

Cancer Gene Ther. 2010 Sep;17(9):664-74. doi: 10.1038/cgt.2010.31. Epub 2010 Jun 4.


Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.

Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.

Cancer Res. 2001 Dec 15;61(24):8743-50.


Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model.

Huang TT, Parab S, Burnett R, Diago O, Ostertag D, Hofman FM, Espinoza FL, Martin B, IbaƱez CE, Kasahara N, Gruber HE, Pertschuk D, Jolly DJ, Robbins JM.

Hum Gene Ther. 2015 Feb;26(2):82-93. doi: 10.1089/hum.2014.100. Epub 2015 Jan 19.


Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.

Portnow J, Synold TW, Badie B, Tirughana R, Lacey SF, D'Apuzzo M, Metz MZ, Najbauer J, Bedell V, Vo T, Gutova M, Frankel P, Chen M, Aboody KS.

Clin Cancer Res. 2017 Jun 15;23(12):2951-2960. doi: 10.1158/1078-0432.CCR-16-1518. Epub 2016 Dec 15.


In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.

Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.

J Gene Med. 2004 Mar;6(3):288-99.


Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors.

Zhao Y, Lam DH, Yang J, Lin J, Tham CK, Ng WH, Wang S.

Gene Ther. 2012 Feb;19(2):189-200. doi: 10.1038/gt.2011.82. Epub 2011 Jun 2.


Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.

Menon LG, Kelly K, Yang HW, Kim SK, Black PM, Carroll RS.

Stem Cells. 2009 Sep;27(9):2320-30. doi: 10.1002/stem.136.


Stem cell therapies for malignant glioma.

Ehtesham M, Stevenson CB, Thompson RC.

Neurosurg Focus. 2005 Sep 15;19(3):E5. Review.


Stem Cell Therapy of Gliomas.

Parker Kerrigan BC, Hossain A, Yamashita S, Lang FF.

Prog Neurol Surg. 2018;32:124-151. doi: 10.1159/000469686. Epub 2018 Jul 10. Review.


Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas.

Zhang Q, Xiang W, Yi DY, Xue BZ, Wen WW, Abdelmaksoud A, Xiong NX, Jiang XB, Zhao HY, Fu P.

Stem Cell Res Ther. 2018 Aug 24;9(1):228. doi: 10.1186/s13287-018-0977-z. Review.


Use of neural stem cells as therapeutic vehicles for the treatment of malignant glioma.

Ehtesham M, Kabos P, Black KL, Yu JS.

Expert Rev Neurother. 2003 Nov;3(6):883-95. doi: 10.1586/14737175.3.6.883.


Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.

Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J.

Cancer Res. 1999 May 15;59(10):2384-94.

Supplemental Content

Support Center